Assessing the Gold Standard — Lessons from the History of RCTs
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Randomized, controlled trials have become the gold standard of medical knowledge. Yet their scientific and political history offers lessons about the complexity of medicine and disease and the economic and political forces shaping the production and circulation of knowledge.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Randomized clinical trials (RCT) serve as the most valid study design to inform clinical practice according to evidence-based medicine (EBM) principles.1,2”
From Integrity of randomized clinical trials: Performance of integrity tests and checklists requires assessment (2023) · cites this paper as [1]
Citations
Cites
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300
Zika Virus Infection in Pregnant Women in Rio de Janeiro
Brasil, P., Pereira, J. P., Moreira, M. E., Ribeiro Nogueira, R. M., Damasceno, L., Wakimoto, M., Rabello, R. S., Valderramos, S. G., Halai, U.-A., Salles, T. S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1602412 · Cited by 2,196
A Controlled Trial of Arthroscopic Surgery for Osteoarthritis of the Knee
Moseley, J. B., O'Malley, K., Petersen, N. J., Menke, T. J., Brody, B. A., Kuykendall, D. H., Hollingsworth, J. C., Ashton, C. M., & Wray, N. P. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013259 · Cited by 2,149
Impure Science: AIDS, Activism, and the Politics of Knowledge
(1997) · Nature Medicine · doi:10.1038/nm0297-242 · Cited by 1,666
The effectiveness of psychotherapy: the Consumer Reports study
Seligman, M. E. P. (1995) · American Psychologist · doi:10.1037/0003-066x.50.12.965 · Cited by 1,608
Emergence of Zaire Ebola Virus Disease in Guinea
Baize, S., Pannetier, D., Oestereich, L., Rieger, T., Koivogui, L., Magassouba, N., Soropogui, B., Sow, M. S., Keïta, S., De Clerck, H., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404505 · Cited by 1,366
TRANSLUMINAL DILATATION OF CORONARY-ARTERY STENOSIS
Grüntzig, A. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90500-7 · Cited by 1,343
Instruments, Randomization, and Learning about Development
Deaton, A. (2010) · Journal of Economic Literature · doi:10.1257/jel.48.2.424 · Cited by 1,286
A review of uses of health care utilization databases for epidemiologic research on therapeutics
Schneeweiss, S., & Avorn, J. (2005) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.10.012 · Cited by 1,277
Research works printed but not linked: 3
- Podolsky SH, Jones DS, Kaptchuk TJ. From trials to trials: blinding, medicine, and honest adjudication. In: Robertson CT, Kesselheim AS, eds. Blinding as a solution to bias: strengthening biomedical science, forensic science, and law. Amsterdam: Elsevier, 2016:45-58.
- Kuo W-H. Japan and Taiwan in the wake of bio-globalization: drugs, race and standards (Ph.D. dissertation). Cambridge: Massachusetts Institute of Technology, 2005.
- Rothman DJ, 2000, New York Rev Books, 47, 60
Cited by
Items 301–400 of 698
Secondary Analysis of Randomized Controlled Trials: Methodological Considerations and Best Practices
Shang, Q., Yao, S., Ouyang, M., Wang, X., & Luo, S. (2025) · Annals of Clinical Epidemiology · doi:10.37737/ace.25017 · Cited by 7
Harrison, T. B., Sinclair, J. A., Martin, L. J., Childers-Buschle, K. E., Elder, H., Fu, S., Liu, H., Brinkman, W. B., Myers, M. F., & McGowan, M. L. (2025) · npj Digital Medicine · doi:10.1038/s41746-025-01947-x · Cited by 9
Prenatal attachment interventions: a comprehensive systematic review and meta-analysis
Coté, J. J., Dilsaver, D. B., Dimmock, J. A., Doehrman, P., Teague, S. J., Coté, R. D., Coté, B. P., Kilzer, R., Sabbaghi, M. O., Borelli, J. L., et al. (2025) · Archives of Women s Mental Health · doi:10.1007/s00737-025-01630-w · Cited by 7
“While interventions to improve prenatal attachment have increased, head-to-head RCT’s are scarce.”
InfluentialLin, S., Zimmerman, E., Datta, S., Selby, M., Chan, T. M., & Fant, A. L. (2023) · AEM Education and Training · doi:10.1002/aet2.10862 · Cited by 8
Myths of Randomized Controlled Trial Analysis in Pediatric Psychopharmacology
Mills, J. A., & Strawn, J. R. (2025) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2025.0005 · Cited by 7
“R andomized controlled trials (RCTs) and the data they produce represent the bedrock of clinical decision-making (Bothwell et al., 2016); they guide treatment selection, prediction of side effects, and treatment sequencing across medicine, including in child and adolescent psychiatry.”
Further Applications of Advanced Methods to Infer Causes in the Study of Physiologic Childbirth
Snowden, J. M., & Tilden, E. L. (2018) · Journal of Midwifery & Women s Health · doi:10.1111/jmwh.12732 · Cited by 7
Therapist effects on dropout in couple therapy
Willis, K., Miller, R. B., Anderson, S. R., Bradford, A. B., Johnson, L. N., & Yorgason, J. B. (2021) · Journal of Marital and Family Therapy · doi:10.1111/jmft.12473 · Cited by 7
“research in medicine was focused on validating the effectiveness of new drugs, with who delivered the drug to a patient seeming of trivial importance compared to the effectiveness of the drug (Bothwell et al., 2016).”
BackgroundAre We Ready for Cryoablation in Children Undergoing Nuss Procedures?
Chidambaran, V., Garcia, V. F., & Brown, R. L. (2022) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005857 · Cited by 7
Patmisari, E., & McLaren, H. (2022) · Trauma Violence & Abuse · doi:10.1177/15248380221113786 · Cited by 10
Honap, S., & Peyrin‐Biroulet, L. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17684 · Cited by 7
Franken, K., ten Klooster, P. M., Bohlmeijer, E. T., Westerhof, G. J., & Kraiss, J. T. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1236551 · Cited by 7
“While the use of such criteria leads to relatively high internal validity, it may decrease external validity and limit generalizability to patient populations treated in daily clinical practice (42–44).”
BackgroundDas, R., Deliu, N., Toshner, M. R., & Villar, S. S. (2025) · Statistical Methods in Medical Research · doi:10.1177/09622802251380625 · Cited by 8
“These drawbacks often prevent successful randomised experimentation and have been widely acknowledged as limiting medical innovation (Bothwell et al., 2016).”
Invisible work, actors, and knowledge: An analysis of a clinical trial for a vaccine to stop smoking
Wolters, A., de Wert, G. M. W. R., van Schayck, O. C. P., & Horstman, K. (2018) · BioSocieties · doi:10.1057/s41292-018-0136-x · Cited by 7
Randomised controlled trials as part of clinical care: A seven‐step routinisation framework proposal
Victoria Team, & Weller, C. D. (2018) · International Wound Journal · doi:10.1111/iwj.13053 · Cited by 7
“However, poorly designed and conducted RCTs may lead researchers to inaccurate conclusions that do not provide the best evidence to inform clinical practice.(14,15) RCTs are particularly Received: 4 October 2018 Revised: 22 November 2018 Accepted: 26 November 2018”
BackgroundProbabilistic thinking and evaluation of therapies: an introductory overview
Tröhler, U. (2020) · Journal of the Royal Society of Medicine · doi:10.1177/0141076820936491 · Cited by 7
“For example, Rosser Matthews considered the rise of the randomised clinical trial in the light of the debates about numerical thinking in the Parisian Academies in the 1830s,(9) and Laura Bothwell et al.(10) studied Lessons from the history of randomized clinical trials (RCT) afterWorldWar II.”
BackgroundAcupuncture – Basic Research and Clinical Application
Litscher, G. (2018) · MDPI eBooks · doi:10.3390/books978-3-03897-235-8 · Cited by 8
Bakhit, M., Jones, M., Baker, J. E., Nair, R., Yan, K., Mar, C. D., & Scott, A. M. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045406 · Cited by 7
Liu, C., Seo, J., Pravodelov, V., Frazier, S., Guy, M., Concilio, K., Lau‐Ng, R., Brandeis, G. H., Watson, J., van der Velde, J., et al. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.100906 · Cited by 7
“The study design was a randomized clinical trial, which is the gold standard for evaluating a new treatment [34].”
MethodPellizzer, M. L., Thompson, M., & Edney, L. C. (2024) · International Journal of Eating Disorders · doi:10.1002/eat.24167 · Cited by 7
Saiani, P. P. (2017) · The American Sociologist · doi:10.1007/s12108-017-9358-9 · Cited by 7
Partial Versus Radical Nephrectomy for the Clinical T1a Renal Mass
Gershman, B., Leibovich, B. C., & Kim, S. P. (2019) · European Urology Focus · doi:10.1016/j.euf.2019.02.005 · Cited by 7
Trials and Tribulations: The Rise and Fall of the RCT in the WASH Sector
Spears, D., Ban, R., & Cumming, O. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780198865360.003.0008 · Cited by 26
Mackowiak, J. I., Mack, C. D., Irwin, D. E., & Zura, R. (2021) · Journal of Orthopaedic Trauma · doi:10.1097/bot.0000000000002040 · Cited by 7
The Trade-off between Impartiality and Freedom in the 21st Century Cures Act
Navarro, D. F., Tempini, N., & Teira, D. (2021) · Philosophy of Medicine · doi:10.5195/philmed.2021.24 · Cited by 8
“…about the interests 7 This is how we read, at least, the non-committal conclusion of “Assessing the Gold Standard: Lessons from the History of RCTs” (Bothwell et al. 2016, 2179): “Originally designed to reduce bias in research, RCTs have become sites of conflicting interests that merit careful…”
BackgroundYang, Z., Liu, P., Luo, Y., Chai, Z., & Yang, B. X. (2024) · Journal of Dentistry · doi:10.1016/j.jdent.2024.105544 · Cited by 7
Ekelund, R., Holmström, S., & Stenling, A. (2025) · International Journal of Sport and Exercise Psychology · doi:10.1080/1612197x.2025.2563323 · Cited by 6
Artificial Intelligence in Drug-Coated Cardiovascular Devices: A Narrative Review
Dinç, R. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm40892 · Cited by 6
“Digital biomarkers enable continuous monitoring us-ing wearable devices and smartphone sensors, providing high-frequency outcome data [ 93–95].”
Mecklenburg, S., & Scheithauer, H. (2026) · International Journal of Developmental Science · doi:10.1177/2192001x261420874 · Cited by 7
“Nearly all analyzed studies were of a conceptual nature or relied on qualitative methods, with no use of statistical or high-validity designs like randomized controlled trials (Bothwell et al., 2016).”
Oester, C., Norris, D., Lovell, R. J., Pedlar, C. R., Bruinvels, G., & Kalkhoven, J. T. (2026) · Sports Medicine · doi:10.1007/s40279-026-02411-w · Cited by 7
“…trials are commonly viewed as a particularly powerful design and often considered the gold standard for estimating causal effects under conditions [260]; however, the notion that RCTs occupy a privileged or universally superior epistemic status is increasingly contested within the causal…”
Liang, N., Ma, X., Cao, Y., Liu, T., Fang, J., & Zhang, X. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303288685240808073238 · Cited by 6
Chen, D. C., He, E., Pace, K., Chekay, M., & Raman, S. (2025) · The Oncologist · doi:10.1093/oncolo/oyaf112 · Cited by 6
The future of precision orthopaedics: personalized data-driven practice
Kader, D. F., Coppola, A., Vijay, A., Fontalis, A., & Haddad, F. S. (2025) · Bone & Joint Open · doi:10.1302/2633-1462.67.bjo-2025-0056.r1 · Cited by 6
“26,27 both RAG and Bayesian methods support the development of ‘explainable AI’, a key advancement over traditional ‘black-box’ AI models, by revealing the sources of their inferences and allowing clinicians to see which data points most strongly influence a prediction.”
Limited impact of real-world evidence in medical oncology: How can AI turn the tide
Pellat, A., & Kather, J. N. (2025) · European Journal of Cancer · doi:10.1016/j.ejca.2025.115714 · Cited by 6
Bao, Z., Gao, W., Xiao, Y., Chai, L., & Liu, Y. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2550857 · Cited by 6
FMT and Microbial Medical Products: Generating High-Quality Evidence through Good Governance
Ossorio, P. N., & Zhou, Y. (2019) · The Journal of Law Medicine & Ethics · doi:10.1177/1073110519897727 · Cited by 8
Srulovici, E., Leventer‐Roberts, M., Curtis, B. H., He, X., Hoshen, M. B., Rotem, M., Reges, O., Key, C., Levin-Iaina, N., Strizek, A., et al. (2020) · Journal of Advanced Nursing · doi:10.1111/jan.14439 · Cited by 6
Williams, T. E., Alexander, S., Blackstone, J., Angelis, F. D., John, N. A., Doshi, A., Beveridge, J., Braisher, M., Gray, E., Chataway, J., et al. (2022) · Trials · doi:10.1186/s13063-022-06588-z · Cited by 6
“Background Randomised controlled trials (RCTs) are the gold-standard for assessing the efficacy and safety of medical treatments [1, 2].”
BackgroundHebestreit, H. U., Lapstich, A.-M., Brandstetter, L., Krauth, C., Deckert, J., Haas, K., Pfister, L., Witt, S., Schippers, C., Dieris-Hirche, J., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102260 · Cited by 6
“29 However, with a randomised controlled study, the risk of contamination of the SC cohort by components of the intervention was considered too high, given the high psychological strain and distress of people with unclear diagnoses.”
Farmers’ attitudes toward economic experimentation
Englberger, L., Colen, L., & Rommel, J. (2025) · Q Open · doi:10.1093/qopen/qoaf005 · Cited by 6
WRIGHT, A. K., Taylor, D., Lowe, M., Barlow, S. G., & Jackson, J. (2025) · Frontiers in Veterinary Science · doi:10.3389/fvets.2025.1502933 · Cited by 6
“Although randomized clinical trials (RCTs) are crucial to determine the effects of treatment in controlled settings, they often lack external validity (24, 25).”
Peabody, J. W., Tran, M. T., Paculdo, D. R., Valdenor, C., Burgon, T. B., & Jeter, E. K. (2019) · Diagnostics · doi:10.3390/diagnostics9030067 · Cited by 6
“Additionally, traditional patient-level RCTs are not as valuable for all study areas [11]: we believe this is the case when investigating behavioral change of the physician whose decisions are proximal to ordering the test and essential to acting upon the test results.”
Hard won lessons learned in the evaluation field: Implications for behavioural insights practice
McDavid, J., & Henderson, K. (2021) · Canadian Public Administration · doi:10.1111/capa.12401 · Cited by 6
“Experimental designs to conduct evaluations can be controversial, deemed by some to be inappropriate on methodological and ethical grounds (Bothwell et al. 2016; Christ 2014).”
BackgroundSicras-Mainar, A., Tornero, J. C., Vargas, F., Lizarraga, I., Sicras, A., & Rejas, J. (2022) · Open Access Rheumatology Research and Reviews · doi:10.2147/oarrr.s346746 · Cited by 6
“This is because such naturalistic, non-interventional studies may be complementary to evidence-based medicine supported by traditional clinical trial research [28,29].”
BackgroundStandards Without Labs: Drug Development in the Psychedelic Underground
Bailey, J., & Kempner, J. (2022) · Citizen Science Theory and Practice · doi:10.5334/cstp.527 · Cited by 7
Unpublished clinical trials of common rheumatic diseases
Pedersen, C., Tai, S., Valley, E., Henry, K. A., Duarte‐García, A., Singla, S., & Putman, M. (2023) · Rheumatology · doi:10.1093/rheumatology/kead141 · Cited by 6
Dansie, K. B., Viecelli, A. K., Pascoe, E. M., Johnson, D. W., McDonald, S., Clayton, P. A., & Hawley, C. M. (2020) · Kidney International · doi:10.1016/j.kint.2020.04.050 · Cited by 6
Results of laparoscopic resection in high-risk rectal cancer patients
Panteleimonitis, S., Figueiredo, N., Bhuvanakrishna, T., Harper, M., & Parvaiz, A. C. (2020) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-020-01892-1 · Cited by 6
Rand, M., Norman, P. E., & Goyder, E. (2020) · BMC Public Health · doi:10.1186/s12889-020-09898-6 · Cited by 6
Jeon, J., Kim, M., Im, Y., Kim, E., Kim, J. S., Kwon, K. T., Hwang, J., Kim, J. S., & Kim, M. (2023) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2882 · Cited by 6
Weaver, J. C., Voss, E. A., Cafri, G., Beyrau, K. K., Nashleanas, M., & Suruki, R. (2024) · BMC Medical Research Methodology · doi:10.1186/s12874-024-02428-7 · Cited by 6
Adapt to survive and thrive: the time is now for adaptive platform trials for preterm birth
Manley, B. J., McKinlay, C. J. D., Lee, K. J., Groom, K. M., & Whitehead, C. L. (2025) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(24)00328-6 · Cited by 5
Revilla, R., Nelson, C. M., Heilman, M. E., Prothro, K., Cheever, A., Hersey, J., Dede, B., & Hudac, C. M. (2025) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.70116 · Cited by 5
“This may generate some bias, as RCTs are considered the ‘gold-standard’ intervention design, and results are often more reliable and valid (Bothwell et al. 2016; Hariton and Locascio 2018).”
Neurodevelopmental effects of perinatal exposure to cannabis on progeny: A narrative review
Azubuike, C. D., Grundmann, O., & Goodin, A. J. (2025) · Drug and Alcohol Dependence Reports · doi:10.1016/j.dadr.2025.100372 · Cited by 5
“Although randomized clinical trials are considered the gold standard in epidemiology studies to establish association between exposures and outcomes (Bothwell et al., 2016; Marcaccio and Schermerhorn, 2024), there are major regulatory barriers to conducting research regarding maternal cannabis…”
Weight loss and all-cause mortality: A propensity score matching cohort study
Zhu, F., Wang, W., Wu, L., Han, S., & Wu, X. (2022) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2022.09.003 · Cited by 5
Development of research methods curriculum for an integrated care fellowship
Bauer, A. M., Cerimele, J. M., & Ratzliff, A. (2021) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2021.04.007 · Cited by 5
McCarthy, M. J., O’Keeffe, L. M., Williamson, P. R., Sydes, M. R., Farrin, A. J., Lugg-Widger, F. V., Davies, G., AVERY, K. N. L., Chan, A., Kwakkenbos, L., et al. (2021) · HRB Open Research · doi:10.12688/hrbopenres.13314.1 · Cited by 5
“(2) Publication of the SPIRIT-ROUTINE extension in journals”
BackgroundA novel element of comprehensive program evaluation: Using a domain matrix design
O’Neal, C. W., & Lucier‐Greer, M. (2022) · Family Relations · doi:10.1111/fare.12673 · Cited by 5
Pan, Y., Sun, X., Tan, J., Deng, C., Wu, C., Osterhoff, G., & Schopow, N. (2025) · Biomedicines · doi:10.3390/biomedicines13010090 · Cited by 5
Holzer, F., & Mastroleo, I. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-805364-5.00001-9 · Cited by 5
Bobby, S., Jenkinson, M. D., Patel, H. C., & Benjamin, D. (2018) · Annals of The Royal College of Surgeons of England · doi:10.1308/rcsann.2018.0174 · Cited by 5
Maher, S., Walsh, S. J., Takyi, J., Wakai, A., Brayden, D. J., & Hayden, J. C. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.10.035 · Cited by 5
Does the RCT tail wag the implementation dog?
Pieterse, P. (2019) · World Development · doi:10.1016/j.worlddev.2019.104821 · Cited by 5
Norton, W. E., Zwarenstein, M., Czajkowski, S. M., Kato, E. U., O’Mara, A. M., Shelburne, N., Chambers, D., & Loudon, K. (2019) · Trials · doi:10.1186/s13063-019-3934-y · Cited by 5
“The first expert discussed the strengths of randomized controlled trials (RCTs) in health [16], reviewed”
BackgroundClinical trial publications: A sufficient basis for healthcare decisions?
Eichler, H., & Rasi, G. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2019.11.022 · Cited by 5
Kumar, N., Ainooson, J., Billings, A., Chen, G. Q., Cueto, L. N., Janmohamed, K., Jiang, J., NIAURA, R. S., & Zhang, A. (2020) · Systematic Reviews · doi:10.1186/s13643-020-01361-2 · Cited by 8
Felder, M. M., van de Bovenkamp, H., Meerding, W. J., & de Bont, A. (2020) · Health Policy · doi:10.1016/j.healthpol.2020.09.006 · Cited by 5
Morduch, J. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780198865360.003.0005 · Cited by 5
Sacks, C. A., North, C. M., Wolf, M., Dougan, M. L., Campbell, K. R., Moggridge, J. A., & Fralick, M. (2021) · Journal of General Internal Medicine · doi:10.1007/s11606-021-07167-9 · Cited by 5
“4 The mechanisms that underlie the variable clinical syndrome caused by SARS-CoV-2 remain an area of active investigation.(3) Many hypotheses have been suggested, which have received heightened publicity in both the scientific and lay press.”
BackgroundSmaller clinical trials for decision making; using p-values could be costly
Graves, N., Barnett, A. G., Burn, E., & Cook, D. (2018) · F1000Research · doi:10.12688/f1000research.15522.1 · Cited by 7
In Silico Clinical Trials: A Possible Response to Complexity in Pharmacology
Boem, F., Malagrinò, I., & Bertolaso, M. (2020) · Boston studies in the philosophy of science · doi:10.1007/978-3-030-29179-2_6 · Cited by 6
Ten Commandments for Randomized Trials of Pharmacological Therapy for COPD and Other Lung Diseases
Suissa, S. (2021) · COPD Journal of Chronic Obstructive Pulmonary Disease · doi:10.1080/15412555.2021.1968816 · Cited by 5
From big data to big impact: realizing the potential of clinical registries
Gill, S. D., & Page, R. S. (2019) · ANZ Journal of Surgery · doi:10.1111/ans.15503 · Cited by 5
“As an alternative to CQRs, randomized controlled trials (RCTs) have been the ‘gold standard’ for determining the effects of interventions for more than 70 years.(10) Randomization improves the internal validity of a trial by evenly distributing known and unknown factors between groups, thereby reducing confounding.”
MethodCogan, P. S. (2020) · Journal of Dietary Supplements · doi:10.1080/19390211.2020.1769246 · Cited by 5
“…not pertain to trials of pharmacotherapeutic efficacy), the evidence base for cannabis derived medications still comes up short as we move down the rungs of most commonly referenced evidence hierarchies (Bothwell et al. 2016; Berlin and Golub 2014; Burns et al. 2011; Grossman and Mackenzie 2005).”
BackgroundBatech, M., Madsen, A. M., Gatto, N. M., Zhang, T. C., Ricci, D. S., Harvey, R. A., Khan, N. S., & Jain, S. (2025) · Health Science Reports · doi:10.1002/hsr2.71272 · Cited by 4
Causal Discovery in Observational Medical Research: Scoping Review
Liu, Z., Luo, T., Ma, H., Mo, J., Yang, X., Huang, Z., Li, J., & Kuang, J. (2026) · JMIR Medical Informatics · doi:10.2196/82499 · Cited by 7
“Although randomized controlled trials (RCTs) remain the gold standard for medical decision-making [7], the limits of RCTs and the growing abundance of observational data underscore an urgent need for more robust causal discovery methodologies.”
Sasaki, M., Sato, H., Uemura, Y., Mikami, A., Ichihara, N., Fujitani, S., Kondo, M., Doi, Y., Morino, E., Tokita, D., et al. (2024) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.3224 · Cited by 4
“4,5 There is growing interest in adaptive platform clinical trials (APTs), which compare multiple drugs to a single common control group, such as a placebo or standard- of-care group, for infectious diseases.”
BackgroundPripp, A. H., Łosińska, K., Korkosz, M., & Haugeberg, G. (2024) · Rheumatology International · doi:10.1007/s00296-024-05597-2 · Cited by 4
Evaluating the current breadth of randomized control trials on cardiac arrest: A scoping review
Toy, J., Friend, L., Wilhelm, K., Kim, M., Gahm, C., Panchal, A. R., Dillon, D., Donofrio-Ödmann, J. J., Montoy, J. C. C., Gausche‐Hill, M., et al. (2024) · Journal of the American College of Emergency Physicians Open · doi:10.1002/emp2.13334 · Cited by 5
“The randomized controlled trial (RCT) has long been considered the gold standard to evaluate therapeutic interventions 7 ; yet, a relative paucity of RCTs exist to inform the definitive management of in-hospital and out-of-hospital cardiac arrest relative to the large public health burden.”
BackgroundJochum, F., Doll, M., Hamy, A., Donval, L., Gougis, P., Dumas, É., Lecointre, L., Gaillard, T., Reyal, F., Lecuru, F. R., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.103053 · Cited by 4
Achieving Precision Medicine in Psoriatic Arthritis
Gunawardana, S., Tillett, W. L., & Coates, L. C. (2025) · Rheumatic Disease Clinics of North America · doi:10.1016/j.rdc.2025.05.007 · Cited by 5
Collet, R. J., Ben, Â. J., Varga, A. N., van Leth, F., Alili, M. E., Eßer, J., Bosmans, J. E., & van Dongen, J. M. (2025) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.70013 · Cited by 7
Dabigatran Compared With Rivaroxaban vs Warfarin—Reply
Parks, A. L., & Redberg, R. F. (2017) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2017.0571 · Cited by 4
Reporting Guidelines for Imaging Research
McInnes, M. D. F., Lim, C. S., van der Pol, C. B., Salameh, J., McGrath, T. A., & Frank, R. A. (2018) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2018.11.008 · Cited by 7
Canepa, M., Marzo, V. D., Ameri, P., Ferrari, R., Tavazzi, L., Rapezzi, C., Porto, I., & Maggioni, A. P. (2023) · ESC Heart Failure · doi:10.1002/ehf2.14459 · Cited by 4
“and have become the gold standard for assessing the effectiveness and safety of interventions.(3) An LoE is assigned to each recommendation in guidelines and the highest LoE”
BackgroundQin, C., Deng, S., Li, B., Zhu, W., Liu, C., Jiang, H., Zhuo, B., Zhang, M., Lyu, Y., Chen, J., et al. (2024) · PLoS ONE · doi:10.1371/journal.pone.0308704 · Cited by 5
“However, incomplete and inadequate RCTs represent a waste that reduces the usefulness of research and failed to benefit clinical practice [16] and it might mislead clinical interventions, ultimately affecting therapeutic effects.”
BackgroundBarghout, S. H., Meti, N., Chotai, S., Kim, C. J. H., Patel, D., Brown, M. C., Hueniken, K., Zhan, L. J., Raptis, S., Al-Agha, F., et al. (2024) · British Journal of Cancer · doi:10.1038/s41416-024-02899-x · Cited by 4
“While randomised controlled trials (RCTs) continue to be the gold standard for evidence generation in oncology [5, 6], the discovery of the complex molecular and genetic nature of cancer has revealed that traditional cancer disease sites can be categorised into smaller, genomic or biomarker-de fi…”
Addressing Confounders in Retrospective Studies
Ensor, J. (2017) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2017.01.002 · Cited by 4
Productivity Benefits of Medical Care: Evidence from US-Based Randomized Clinical Trials
Chen, A. J., & Goldman, D. P. (2018) · Value in Health · doi:10.1016/j.jval.2018.01.009 · Cited by 4
Polaschek, D. L. L. (2019) · Wiley eBooks · doi:10.1002/9781119139980.ch25 · Cited by 4
Krishnamoorthy, V. K., Ellis, A. R., McLean, D. J., Stefan, M. S., Nathanson, B. H., Cobert, J. M., Lindenauer, P. K., Brookhart, M. A., Ohnuma, T., & Raghunathan, K. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004942 · Cited by 4
Adaptive design methods in dialysis clinical trials: a systematic review protocol
Judge, C. S., Murphy, R., Cormican, S., Smyth, A., O’Halloran, M., & O'Donnell, M. J. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-036755 · Cited by 4
Garchitorena, A., Murray, M. B., Hedt‐Gauthier, B., Farmer, P. E., & Bonds, M. H. (2020) · Oxford University Press eBooks · doi:10.1093/oso/9780198865360.003.0007 · Cited by 5
Herausforderungen von Evidenzlevel-1-Studien in der Unfallchirurgie und Orthopädie
Guenther, D., Herbst, E., Laky, B., Lattermann, C. M., Mathis, D. T., Rößler, P., Schüttler, K. F., Wafaisade, A., & Kopf, S. (2021) · Arthroskopie · doi:10.1007/s00142-021-00469-4 · Cited by 4
Zhang, X., Chen, L., Bracco, O. L., Setoguchi, S., Zhou, W., & Burcu, M. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2450 · Cited by 4
“14 Randomized clinical trials (RCTs) are recognized as the gold standard in collecting clinical evidence on the safety and efficacy of oncology drugs pre- approval.(15) However, RCTs cannot answer all the important questions including safety (e.”
BackgroundPerioperative Efficiency of Sugammadex Following Laparoscopic Cholecystectomy in Clinical Practice
Lee, C. R., Ahsan, H., Chae, H., Esnard, D. M., Broussard, D. M., Hart, S., Allain, A., Bond, B., Busch, E. H., Jhita, P. K., et al. (2022) · Ochsner Journal · doi:10.31486/toj.22.0064 · Cited by 4
“Age, years, median [IQR] 49 [35-62] 47 [33-61] –0.”
Fan, W., Guo, W., & Chen, Q. (2024) · Clinical and Experimental Obstetrics & Gynecology · doi:10.31083/j.ceog5106147 · Cited by 4
“RCTs have superior study designs owing to their internal validity; however, they may lack external validity [37–39].”
BackgroundSmaller clinical trials for decision making; a case study to show p-values are costly
Graves, N., Barnett, A. G., Burn, E., & Cook, D. (2018) · F1000Research · doi:10.12688/f1000research.15522.2 · Cited by 4
Koterov, A. N., Tikhonova, O. A., Ushenkova, L. N., & Biryukov, A. P. (2021) · FARMAKOEKONOMIKA Modern Pharmacoeconomics and Pharmacoepidemiology · doi:10.17749/2070-4909/farmakoekonomika.2021.059 · Cited by 5
A landscape of methodology and implementation of adaptive designs in cancer clinical trials
Zhu, Y., Wang, W.-X., Cheuk, S.-K., Feng, G., Li, X.-G., Peng, J., Liu, Y., Yu, S.-R., Tang, J.-L., Chow, S.-C., et al. (2024) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2024.104402 · Cited by 3
Lin, S., Wu, C., & Pan, Y. (2025) · Journal of Pain Research · doi:10.2147/jpr.s523677 · Cited by 3
Metadata
- Authors
- Bothwell, L. E., Greene, J. A., Podolsky, S. H., & Jones, D. S.
- Affiliations
- Brigham and Women's Hospital (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-06-02
- Volume
- 374
- Issue
- 22
- Pages
- 2175-2181
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2413861456
- Cited by
- 664
- References
- 54
- Citations by year
- 2026: 40 · 2025: 101 · 2024: 59 · 2023: 53 · 2022: 49 · 2021: 76 · 2020: 93 · 2019: 71 · 2018: 74 · 2017: 43 · 2016: 5
- FWCI
- 337.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Arts and Humanities › History and Philosophy of Science › History of Science and Medicine
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Social Sciences › Arts and Humanities › History and Philosophy of Science › Philosophy of Biology and Scientific Explanation
- Keywords
- randomized controlled trials, history of medicine, evidence-based medicine, scientific knowledge production, medical politics, health research funding
- MeSH terms
- Drug Industry, Female, Humans, Legislation, Drug, Pregnancy, Randomized Controlled Trials as Topic, Drug Approval, History, 20th Century, History, 21st Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.